Comparison

DX3-213B European Partner

Item no. TMO-T63136-100mg
Manufacturer TargetMol
CASRN 2749555-66-4
Amount 100 mg
Category
Type Inhibitors
Specific against other
Smiles S(=O)(=O)(N1C[C@H](C(=O)N2CCC(F)(F)CC2)CCC1)C3=CC=C(S(C(C)C)(=O)=O)C=C3
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Short Description
DX3-213B is a potent, orally active inhibitor of oxidative phosphorylation (OXPHOS) complex I with an IC50 of 3.6 nM. DX3-213B blocks ATP production (IC50: 11 nM) and inhibits the growth of MIA PaCa-2 cells (GI50: 11 nM). DX3-213B can be used to study pancreatic cancer.
Shipping
cool pack
Storage
-20°
Molecular Weight
478, 57
Pathway
Apoptosis
Target
OXPHOS

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close